Malignant neuroendocrine pulmonary tumors associated with Cushing syndrome are often treated with surgical removal. Researchers sought ways to predict outcomes and potentially lung-sparing surgical methods.
Mild autonomous cortisol secretion (MACS) from benign adrenal tumors is associated with increased cardiometabolic risk.
The complexity of Cushing syndrome often makes diagnosis difficult. Researchers sought to create a diagnostic tool that could determine which patients may be at risk for developing the disease.
Adrenal masses and people who may have Cushing syndrome are often evaluated with a dexamethasone suppression test (DST), but false positives occur. Researchers examined whether free cortisol assessment during DST would aid in diagnosis.
Children with well-controlled congenital adrenal hyperplasia may not need additional growth treatment; bone age may not be an accurate predictor.
Global population numbers are predicted to peak in several decades and then shrink by 50% in some countries; researchers want to know why.
Patients with stage II or IV disease did not fare as well as patients with stage I or III disease.
Investigators sought to measure the association between mortality and levels of autonomous cortisol secretion in patients with adrenal incidentalomas.
A team of researchers conducted genetic analyses of children and adolescents with primary adrenal insufficiency of unknown etiology to provide insight into diagnosing this and other related conditions.
A team of investigators conducted a phase 3, multicenter study with a double-blind, randomized withdrawal period to assess the effects of twice-daily osilodrostat in patients with Cushing disease.
A team of investigators reviewed data from the 2018 Nationwide Inpatient Sample to assess the impact of obesity on outcomes in patients hospitalized for adrenal insufficiency.